James E. Fickenscher, Chief Financial Officer at Zynerba Pharmaceuticals, Inc. (ZYNE), bought 17,036 shares at $5.97 ($102K) on 2018-08-06, disclosed to the SEC on 2018-08-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.97 | 8,518 | $51K | 50.0% |
| 2 | $5.97 | 8,518 | $51K | 50.0% |
| Total | $5.97 avg | 17,036 | $102K | 100% |
| Filing → |
| ZYNE | SELL | 2022-07-20 | $7K | — | Filing → |
| ZYNE | BUY | 2017-05-16 | $103K | — | Filing → |
| ZYNE | BUY | 2016-12-08 | $99K | — | Filing → |